Full-Time
Personalized healthcare solutions using AI/ML
$150k - $175k/yr
Senior
Remote in USA
This role is fully remote but is intended for candidates based in the US.
Ostro aims to enhance health outcomes by creating personalized healthcare experiences for consumers and healthcare professionals (HCPs). Its products include Ostro Tailor, which uses AI to deliver approved content to HCPs, and Ostro Navigate, which guides users through their healthcare journeys. Ostro Attribute connects online and offline activities through analytics to improve digital marketing effectiveness for life sciences brands. The company stands out by integrating advanced technology into its offerings, with the goal of empowering individuals and HCPs to make informed health decisions.
Company Size
51-200
Company Stage
Early VC
Total Funding
$71.3M
Headquarters
Miami, Florida
Founded
2019
Help us improve and share your feedback! Did you find this helpful?
Remote Work Options
Unlimited Paid Time Off
Health Insurance
Dental Insurance
Vision Insurance
Home Office Stipend
Company Equity
Havas today announced a strategic investment and partnership with Ostro, the trailblazing AI-powered engagement platform built for the life sciences... Read More
Diefenbach joins ODAIA from Ostro, where he was Senior Vice President.
“Ostro is so proud to partner with CooperSurgical on their initiative to improve patient centricity and access to care,” said Ahmed Elsayyad, President, Ostro.
At the same time, Ostro launched a new website and brand identity, grew annual revenue by over 250%, increased the employee base by 50%, and closed an additional $45 million in funding from Founders Fund, Byers Capital, Caffeinated Capital, Greycroft, Bling Capital, Trust Ventures, and RRE Ventures, bringing total funding to over $55M.
Technology partnership aims to increase engagement by educating consumers about CooperSurgical's ParagardTRUMBULL, Conn., Dec. 14, 2022 /PRNewswire/ -- CooperSurgical, Inc., a leader in women's healthcare, and Ostro , a leading engagement platform dedicated to educating and empowering consumers and healthcare providers, today announced their partnership to launch a new consumer engagement solution for CooperSurgical's hormone-free IUD, Paragard. Paragard is an FDA-approved intrauterine device that prevents pregnancy for up to 10 years."By partnering with Ostro, we are truly accelerating what's possible." - Holly Sheffield, President, CooperSurgical Tweet this CooperSurgical logo"CooperSurgical is dedicated to putting time on the side of women, babies, and families at the moments that matter the most in life. Patient education along with access to care is at the forefront of our mission," said Holly Sheffield, President, CooperSurgical. "By partnering with Ostro, we are truly accelerating what's possible. We are empowering women to take control of their future."With the implementation of the Ostro technology, Paragard will now offer consumers a more personalized experience on Paragard.com that includes the option of connecting with a live Nurse Navigator who can answer questions and assist patients in determining if Paragard may be right for them